MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

29.41 0.55

Buy Sell

Overview

Share price change

24h

Current

Min

28.75

Max

29.41

Key metrics
By Trading Economics
Income	-28M 22M
Sales	4.3M 244M
P/E Sector Avg	10.72 63.808
Profit margin	9.224
Employees	293
EBITDA	-22M 52M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+41.17% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	133M 1.7B
Previous open	28.86
Previous close	29.41

News Sentiment

By Acuity

50%

167 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 kwi 2026, 23:14 UTC

Earnings

Battery Maker CATL First-Quarter Net Rose on Strong Demand

15 kwi 2026, 23:14 UTC

Earnings

Battery Maker CATL First Quarter Net Rose On Strong Demand

15 kwi 2026, 17:13 UTC

Major Market Movers

Tesla Shares Rise on Completion of AI5 Chip Design Process

15 kwi 2026, 23:39 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

15 kwi 2026, 23:35 UTC

Market Talk

Major News Events

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

15 kwi 2026, 22:41 UTC

Earnings

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

15 kwi 2026, 22:38 UTC

Earnings

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

15 kwi 2026, 22:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 kwi 2026, 22:15 UTC

Market Talk

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

15 kwi 2026, 22:14 UTC

Earnings

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

15 kwi 2026, 22:12 UTC

Earnings

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

15 kwi 2026, 22:11 UTC

Earnings

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

15 kwi 2026, 22:11 UTC

Earnings

Lens Technology Swings to Loss in 1Q>300433.SZ

15 kwi 2026, 22:07 UTC

Earnings

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

15 kwi 2026, 21:34 UTC

Acquisitions, Mergers, Takeovers

Skild AI Acquires Zebra Technologies' Robotics Automation Business

15 kwi 2026, 21:29 UTC

Hot Stocks

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

15 kwi 2026, 20:50 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

15 kwi 2026, 20:30 UTC

Earnings

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

15 kwi 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15 kwi 2026, 20:06 UTC

Market Talk

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

15 kwi 2026, 19:46 UTC

Earnings

Acquisitions, Mergers, Takeovers

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

15 kwi 2026, 19:25 UTC

Market Talk

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

15 kwi 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

15 kwi 2026, 18:58 UTC

Market Talk

Major News Events

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

15 kwi 2026, 18:11 UTC

Acquisitions, Mergers, Takeovers

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

15 kwi 2026, 17:45 UTC

Acquisitions, Mergers, Takeovers

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

15 kwi 2026, 16:58 UTC

Earnings

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

15 kwi 2026, 16:52 UTC

Earnings

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

15 kwi 2026, 16:46 UTC

Market Talk

Major News Events

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

15 kwi 2026, 16:37 UTC

Market Talk

Earnings

Global Equities Roundup: Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

41.17% upside

12 Months Forecast

Average 41.25 USD 41.17%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

167 / 348 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.